J031-1109 Screening compound: 4-bromo-N-[(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)methyl]benzamide

J031-1109 Screening compound: 4-bromo-N-[(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)methyl]benzamide
J031-1109 Screening compound: 4-bromo-N-[(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)methyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound J031-1109
4-bromo-N-[(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)methyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J031-1109

Molecular Formula

C17H16BrNO3 (C17 H16 BrNO3)

Compound Name

4-bromo-N-[(3,4-dihydro-2H-1,5-benzodioxepin-7-yl)methyl]benzamide

IUPAC name

4-bromo-N-[(34-dihydro-2H-15-benzodioxepin-7-yl)methyl]benzamide

SMILES

O=C(c(cc1)ccc1Br)NCc(cc1)cc2c1OCCCO2

InChI

InChI=1S/C17H16BrNO3/c18-14-5-3-13(4-6-14)17(20)19-11-12-2-7-15-16(10-12)22-9-1-8-21-15/h2-7,10H,1,8-9,11H2,(H,19,20)

InChI Key

YNULMMPRNXXCHB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27220870

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

362.22

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

3.042

Distribution Coefficient, logD

3.042

Water Solubility, LogSw

-3.20

Polar Surface Area

40.806

Acid Dissociation Constant (pKa)

12.27

Base Dissociation Constant (pKb)

-3.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.50

J031-1109 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

Anticancer Library (62698 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Antibacterial Compounds Library (13827 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Infections
  • Immune system
  • animal
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with J031-1109 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J031-1109?
Check Price and Availability of J031-1109, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J031-1109 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J031-1109
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J031-1109
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J031-1109 available by request